Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

NCT03158038 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Healthy

Interventions

BIOLOGICAL: Monovalent Influenza Vaccine
OTHER: Placebo

Sponsor

MedImmune LLC

Collaborators

[object Object]